Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-19-033001

Director bought 15,000 shares at $1.45 ($21,750)

From the SEC's structured data for this filing

Trades in this filing

ASELAGE STEVE · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-11-18 Purchase : show line 1 in the form +15,000 $1.45 $21,750 21,672 D
Open-market purchases · 15,000 sh · avg $1.45 · $21,750
Loading xslF345X03/form4.xml…